Search
for

    Sort by

    Research 961–990 of 1000+

    1. Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab Breast Cancer Basic and Clinical Research · 2018 · 12 citations
    2. Drug safety evaluation of exemestane Expert Opinion on Drug Safety · 2011 · 7 citations
    3. Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial ESMO Open · 2025 · 2 citations
    4. Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer Clinical breast cancer · 2003 · 108 citations
    5. Radyoterapinin Metastatik Meme Kanseri Hücrelerindeki Mitokondri İlişkili Yolaklar Üzerine Etkisi Ege Tıp Bilimleri Dergisi · 2025
    6. Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis Expert Review of Anticancer Therapy · 2017 · 28 citations
    7. CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients. Journal of Clinical Oncology · 2019 · 4 citations
    8. Novel electroporation-based treatments for breast cancer Advances in Clinical and Experimental Medicine · 2022 · 3 citations
    9. A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative) Future Oncology · 2025
    10. In-Vitro Anticancer Activity of Chemical Constituents from Etlingera alba Poulsen against Triple Negative Breast Cancer and in silico Approaches towards Matrix metalloproteinase-1 Inhibition Indonesian Journal of Science and Technology · 2022 · 7 citations
    11. Predisposing and Overall Effects of Reproductive Hormones on Breast Cancer: A Review Curēus · 2023
    12. A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib Journal of Comparative Effectiveness Research · 2024 · 7 citations
    13. Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer Neoplasma · 2010 · 6 citations
    14. Outcome and clinical–biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases Annals of Oncology · 2012 · 2 citations
    15. Ki-67 Levels and Their Association With Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Prospective Observational Study Cureus · 2025 · 2 citations
    16. Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®) European journal of oncology nursing · 2004 · 35 citations
    17. Clinical Case Notes. Tamoxifen optic neuropathy Clinical and Experimental Ophthalmology · 2004 · 23 citations
    18. Kemoterapinin En Görünen Yönü: Alopesi: Önlemek Mümkün Mü? SDÜ SAĞLIK BİLİMLERİ DERGİSİ · 2018
    19. Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel Drug safety · 2023 · 3 citations
    20. Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report Curēus · 2024
    21. Rapid generation of homogenous tumor spheroid microtissues in a scaffold-free platform for high-throughput screening of a novel combination nanomedicine PLoS ONE · 2023 · 18 citations
    22. News in brief Expert Review of Endocrinology & Metabolism · 2011
    23. DRUG NEWS ​​​​​​​​​​​​​​Nursing2023 · 2013
    24. LOP14 Plastic and Reconstructive Surgery · 2014
    25. LOP14 Plastic and Reconstructive Surgery · 2014
    26. Certain Cancer Myths Endure, with Impact on Treatment, Prevention, Screening Oncology Times · 2004
    27. Complex Scalp Reconstruction with Super Thin DIEP Free Flap Plastic & Reconstructive Surgery Global Open · 2024 · 1 citations
    28. RANK as a therapeutic target in cancer ˜The œFEBS journal · 2016 · 50 citations
    29. NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders Journal of Medicinal Chemistry · 2025 · 45 citations
    30. Clinical Case Notes. Intraorbital ophthalmic artery aneurysms Clinical and Experimental Ophthalmology · 2004 · 20 citations